Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicaid Expansion Demos Give Drug Firms A Break From Rebates

Executive Summary

CMS has approved an expansion of Medicaid that would not include rebates for drugs used by the newly eligible population under the Affordable Care Act. The agency is also evaluating a demonstration from Iowa that does not collect drug rebates on individuals eligible under ACA.

You may also be interested in...



Big Data Transforming The Role Of Pharma, IBM Analytics Partner Says

Pharmaceutical companies are beginning to leverage big data to become more integrated into health care delivery, looking to care coordination and other “services adjacent to medicines,” IBM’s John Piccone reports.

CMS To Issue Guidance Interpreting Affordable Care Act's Effect On Medicaid Formularies

Confusion has arisen as to whether the health reform statute's changes to Medicaid drug rebates means that a state Medicaid program's fee-for-service and managed care organization formularies must be identical.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

UsernamePublicRestriction

Register

ID034708

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel